BBusiness Read More Zealand stock plummets after trial setback, CEO remains optimisticMarch 7, 2026 Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management…
HHealthcare Read More Eli Lilly launches program to boost employer coverage of obesity drugsMarch 5, 2026 Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
HHealthcare Read More Why Novo Nordisk’s Ireland expansion is key to fighting off Eli LillyMarch 2, 2026 Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
HHealthcare Read More What’s next for Novo Nordisk’s obesity drug CagriSemaFebruary 24, 2026 A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
AArtificial intelligence Read More The market is so on edge about AI that it’s selling off Monday on an unlikely sourceFebruary 23, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
HHealthcare Read More Eli Lilly launches Zepbound obesity drug pen with one month of dosesFebruary 23, 2026 An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March…
MMedication Read More Hims & Hers announces Wegovy pill copy; Novo Nordisk vows legal actionFebruary 6, 2026 The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark,…
HHealthcare Read More Eli Lilly (LLY) earnings Q4 2025February 4, 2026 Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
HHealthcare Read More Pfizer’s monthly obesity injection drove shows promise in trialFebruary 3, 2026 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it…
HHealthcare Read More Eli Lilly CEO David Ricks talks Medicare coverage of obesity pillsJanuary 30, 2026 Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major…
HHealthcare Read More Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugsJanuary 30, 2026 Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik…
HHealthcare Read More 15 drugs added to Medicare price negotiationsJanuary 28, 2026 Boxes of the drug trulicity, made by Eli Lilly and Company, sit on a counter at a pharmacy…